Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Grifols
|
| gptkbp:acquisitionYear |
2011
|
| gptkbp:founded |
2005
|
| gptkbp:headquarters_location |
gptkb:Research_Triangle_Park,_North_Carolina,_United_States
|
| gptkbp:industry |
biopharmaceuticals
|
| gptkbp:numberOfEmployees |
over 4,700 (at time of acquisition)
|
| gptkbp:parentCompany |
gptkb:Grifols
|
| gptkbp:products |
plasma-derived therapies
|
| gptkbp:publiclyTraded |
yes
|
| gptkbp:stockSymbol |
gptkb:TLCR
|
| gptkbp:website |
www.talecris.com
|
| gptkbp:bfsParent |
gptkb:CSL_Limited
|
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
Talecris Biotherapeutics
|